Literature DB >> 9882380

DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism.

K E Willetts1, F Rey, I Agostini, J M Navarro, Y Baudat, R Vigne, J Sire.   

Abstract

The Vpr protein, encoded by the human immunodeficiency virus type 1 (HIV-1) genome, is one of the nonstructural proteins packaged in large amounts into viral particles. We have previously reported that Vpr associates with the DNA repair enzyme uracil DNA glycosylase (UDG). In this study, we extended these observations by investigating whether UDG is incorporated into virions and whether this incorporation requires the presence of Vpr. Our results, with highly purified viruses, show that UDG is efficiently incorporated either into wild-type virions or into Vpr-deficient HIV-1 virions, indicating that Vpr is not involved in UDG packaging. Using an in vitro protein-protein binding assay, we reveal a direct interaction between the precursor form of UDG and the viral integrase (IN). Finally, we demonstrate that IN-defective viruses fail to incorporate UDG, indicating that IN is required for packaging of UDG into virions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882380      PMCID: PMC103999     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

Authors:  F Rey; M BouHamdan; J M Navarro; I Agostini; K Willetts; M Bouyac; C Tamalet; B Spire; R Vigne; J Sire
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

2.  The purification of a mismatch-specific thymine-DNA glycosylase from HeLa cells.

Authors:  P Neddermann; J Jiricny
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

3.  Specific incorporation of cyclophilin A into HIV-1 virions.

Authors:  E K Franke; H E Yuan; J Luban
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

4.  Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.

Authors:  C Lavallée; X J Yao; A Ladha; H Göttlinger; W A Haseltine; E A Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.

Authors:  S P Layne; M J Merges; M Dembo; J L Spouge; S R Conley; J P Moore; J L Raina; H Renz; H R Gelderblom; P L Nara
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

6.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

Authors:  W Paxton; R I Connor; N R Landau
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

Authors:  N K Heinzinger; M I Bukrinsky; S A Haggerty; A M Ragland; V Kewalramani; M A Lee; H E Gendelman; L Ratner; M Stevenson; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.

Authors:  M E Rogel; L I Wu; M Emerman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  28 in total

1.  Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.

Authors:  Fei Guo; Shan Cen; Meijuan Niu; Jenan Saadatmand; Lawrence Kleiman
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 2.  Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.

Authors:  Réjean Cantin; Sylvie Méthot; Michel J Tremblay
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.

Authors:  Shari M Kaiser; Michael Emerman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  HIV DNA is heavily uracilated, which protects it from autointegration.

Authors:  Nan Yan; Elizabeth O'Day; Lee Adam Wheeler; Alan Engelman; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 5.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.

Authors:  Bärbel Schröfelbauer; Qin Yu; Samantha G Zeitlin; Nathaniel R Landau
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice.

Authors:  Frank S De Silva; Bernard Moss
Journal:  Virol J       Date:  2008-12-02       Impact factor: 4.099

8.  Identification of host proteins associated with HIV-1 preintegration complexes isolated from infected CD4+ cells.

Authors:  Nidhanapati K Raghavendra; Nikolozi Shkriabai; Robert Lj Graham; Sonja Hess; Mamuka Kvaratskhelia; Li Wu
Journal:  Retrovirology       Date:  2010-08-11       Impact factor: 4.602

9.  Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.

Authors:  Christelle Langevin; Priscilla Maidou-Peindara; Per Arne Aas; Guillaume Jacquot; Marit Otterlei; Geir Slupphaug; Serge Benichou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.

Authors:  David Fenard; Laurent Houzet; Eric Bernard; Audrey Tupin; Sonia Brun; Marylène Mougel; Christian Devaux; Nathalie Chazal; Laurence Briant
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.